Corix Bioscience (Corix Bioscience) ROCE % : -17.55% (As of Sep. 2017)

View and export this data going back to 2008. Start your Free Trial

What is Corix Bioscience ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Corix Bioscience's annualized ROCE % for the quarter that ended in Sep. 2017 was -17.55%.

Corix Bioscience ROCE % Historical Data

The historical data trend for Corix Bioscience's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corix Bioscience ROCE % Chart

Corix Bioscience Annual Data

Trend

Jan09

Jan10

Jan11

Jan12

Jan13

Jan14

Jan15

Dec16

ROCE %

Get a 7-Day Free Trial

-37.86

Corix Bioscience Quarterly Data
	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17
ROCE %	Get a 7-Day Free Trial															-12.27	-114.40	-2.43	-62.91	-17.55

Corix Bioscience ROCE % Calculation

Corix Bioscience's annualized ROCE % for the fiscal year that ended in Dec. 2016 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2016 )		(A: Jan. 2015 )		(A: Dec. 2016 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2016 )		(A: Jan. 2015 )		(A: Dec. 2016 )
	=	-4.045	/	( ( (0 - 0)	+	(11.37 - 0.687) )	/ 1 )
	=	-4.045	/	( (0	+	10.683)	/ 1 )
	=	-4.045	/	10.683
	=	-37.86 %

Corix Bioscience's ROCE % of for the quarter that ended in Sep. 2017 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2017 )		(Q: Jun. 2017 )		(Q: Sep. 2017 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2017 )		(Q: Jun. 2017 )		(Q: Sep. 2017 )
	=	-1.124	/	( ( (10.457 - 1.205)	+	(4.344 - 0.786) )	/ 2 )
	=	-1.124	/	( ( 9.252	+	3.558 )	/ 2 )
	=	-1.124	/	6.405
	=	-17.55 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2017) EBIT data.

Corix Bioscience (GREY:CXBS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Corix Bioscience ROCE % Related Terms

Thank you for viewing the detailed overview of Corix Bioscience's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Corix Bioscience (Corix Bioscience) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Corix Bioscience Inc (GREY:CXBS) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

18662 MaCaurther Boulevard, Suite 200, Irvine, CA, USA, 85085

Website

http://www.corixbioscience.com

Corix Bioscience Inc is a United States-based research and development firm of cannabidiol (CBD) products and treatments. It is engaged in the business of producing organic CBD oil used for medical applications and treatments. In addition, the group is also focused on the production of tetrahydrocannabivarin oil. The company is focused on operations in Oregon, California, and Nevada, United States.

Corix Bioscience (Corix Bioscience) Headlines

No Headlines